Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective
This study reveals that infliximab SC is associated with cost-saving potential when compared to infliximab IV formulations available in Saudi Arabia. Future research should address uncertainties related to real-world comparative effectiveness, the convenience of administration, patient tolerability, and physician acceptance of the SC formulation of infliximab, alongside comparisons with other TNF-alpha inhibitors.
Authors
- Mahmoud Mosli (ORCID: https://orcid.org/0000-0002-6975-1297)
- Majed S. Al Yami (ORCID: https://orcid.org/0000-0003-2308-8407)
- Nahla Azzam (ORCID: https://orcid.org/0000-0002-2097-289X)
- Abdulaziz Alhossan (ORCID: https://orcid.org/0000-0001-5849-6756)
- Samah F. Al‐Shatnawi
- Nimer S. Alkhatib (ORCID: https://orcid.org/0000-0001-5071-9257)
- Amal M. Badawoud (ORCID: https://orcid.org/0000-0001-7718-562X)
- Omar Rashdan (ORCID: https://orcid.org/0000-0002-5192-4823)
- Yazed AlRuthia (ORCID: https://orcid.org/0000-0002-0029-5924)
- Shiraz Halloush (ORCID: https://orcid.org/0000-0003-3966-2733)
- Majid A. Almadi (ORCID: https://orcid.org/0000-0001-9917-2758)
- Abdulaali R. Almutairi (ORCID: https://orcid.org/0000-0002-3141-0606)
- Ibtisam Alharbi
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- Al-Zaytoonah University of Jordan (JO)
- Applied Science Private University (JO)
- Jordan University of Science and Technology (JO)
- King Abdulaziz University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Water Authority of Jordan (JO)
- Montreal General Hospital (CA)
- King Saud Medical City (SA)
- King Saud University (SA)
- Saudi Arabian Monetary Authority (SA)
- King Fahd Armed Forces Hospital (SA)
- King Abdulaziz Hospital (SA)
- McGill University (CA)
- Middle East University (JO)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-11-12
- DOI
- https://doi.org/10.1371/journal.pone.0312603
- Citations
- 3
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.65
Funders
- Princess Nourah Bint Abdulrahman University